Praxis develops neurology drugs for movement disorders.
Praxis Precision Medicines, Inc. (PRAX) is expected to report earnings on Monday, November 9, 2026, after the close. Estimated release time 08:33 ET. Consensus EPS estimate is $-3.65.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2025-02-28 | FY2024 Q4 | $-2.76 | $-2.94 | -6.5% | — |
| 2024-11-06 | FY2024 Q3 | $-2.01 | $-2.75 | -36.8% | $302.00K |
| 2024-08-13 | FY2024 Q2 | $-2.38 | $-1.74 | +26.9% | $357.00K |
| 2024-05-13 | FY2024 Q1 | $-2.01 | $-2.84 | -41.3% | $431.00K |
| 2024-03-05 | FY2023 Q4 | $-3.15 | $-2.97 | +5.7% | — |
| 2023-11-07 | FY2023 Q3 | $-5.25 | $-2.72 | +48.2% | $468.00K |
| 2023-08-09 | FY2023 Q2 | $-9.90 | $-7.38 | +25.5% | $781.00K |
| 2023-05-11 | FY2023 Q1 | $-11.24 | $-10.58 | +5.9% | $683.00K |
PRAX has beaten consensus EPS in 5 of its last 8 reported quarters.
See PRAX on the live calendar →